Xiangxue Life Sciences
Industry
- Biotechnology
See more in Biomedtracker
Latest on Xiangxue Life Sciences
Scrip
• By Ian Haydock, Vibha Ravi, Jung Won Shin, Joseph Haas, Brian Yang, and Anju Ghangurde
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Curon Picks Up China-Plus Rights to Rhi
Pink Sheet
• By Brian Yang
It started from a usual busy shopping season at a local foodstuff market, and quickly spread to the whole city and many cities beyond. January is usually a busy shopping time for people in China as th
Scrip
• By Joseph Haas, Jo Shorthouse, Alex Shimmings, Jung Won Shin, and Kevin Grogan
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in